Identify the structural properties of TDP-43 C-terminal fragments associated with ALS

Identify the structural properties of TDP-43 C-terminal fragments associated with ALS

碩士 === 國立臺灣科技大學 === 工程技術研究所 === 98 === Many neurodegenerative diseases (NDDs), including Alzheimer’s disease (AD), Huntington’s disease (HD), Motor neuron disease (MND), Parkinson’s disease (PD), and Amyotrophic lateral sclerosis (ALS), have been realized to associate with inclusion body formation a...

Full description

Bibliographic Details
Main Authors:	Yeh-Yung Lin, 林燁雍
Other Authors:	Jen-Tse Huang
Format:	Others
Language:	en_US
Published:	2010
Online Access:	http://ndltd.ncl.edu.tw/handle/26467456337245555321

Similar Items

The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD
by: Britt A. Berning, et al.
Published: (2019-04-01)

Characterization of the aggregation propertis of amyloid core in the TDP-43 C-terminal fragments
by: Chun-Hao Liu, et al.
Published: (2012)

The condensate formation property of the C-terminal domain of TDP-43
by: Wan-Chin Chiang, et al.
Published: (2018)

The influence of TDP-43 aggregation by its C-terminal fragments and cognate DNA/RNA
by: Huang Yi-Chen, et al.
Published: (2013)

Characterizing the self-association and phase-separation properties of C-terminal domain of TDP-43
by: Hao-Ru Li, et al.
Published: (2017)

Structural and biochemical properties of the ALS-linked mutations in TDP-43
by: Chiang, Chien Hao, et al.
Published: (2016)

Characterizing the phase transition properties of the intrinsically disordered C terminal domain of TDP 43
by: Ta-Wei Yu, et al.
Published: (2019)

Electrostatic Repulsion Governs TDP-43 C-terminal Domain Aggregation.
by: Miguel Mompeán, et al.
Published: (2016-04-01)

Molecular, functional, and pathological aspects of TDP-43 fragmentation
by: Deepak Chhangani, et al.
Published: (2021-05-01)

Characterize the biophysical and chemical properties of TDP-43 in ALS
by: Chu-ya Wu, et al.
Published: (2011)

The C-terminal TDP-43 fragments have a high aggregation propensity and harm neurons by a dominant-negative mechanism.
by: Chunxing Yang, et al.
Published: (2010-12-01)

C-terminal and full length TDP-43 specie differ according to FTLD-TDP lesion type but not genetic mutation
by: Keith A. Josephs, et al.
Published: (2019-07-01)

The N-terminal dimerization is required for TDP-43 splicing activity
by: Lei-Lei Jiang, et al.
Published: (2017-07-01)

TDP-43 and Limbic-Predominant Age-Related TDP-43 Encephalopathy
by: Lumi Zhang, et al.
Published: (2020-01-01)

DCTN1 Binds to TDP-43 and Regulates TDP-43 Aggregation
by: Manami Deshimaru, et al.
Published: (2021-04-01)

Prion-like mechanisms of TDP-43 in ALS
by: Smethurst, P.
Published: (2014)

ALS-associated TDP-43 induces endoplasmic reticulum stress, which drives cytoplasmic TDP-43 accumulation and stress granule formation.
by: Adam K Walker, et al.
Published: (2013-01-01)

The Aggregation Properties of Amyloidogenic Peptides in TDP-43
by: Yu-Ju Tsai, et al.
Published: (2016)

Spreading of TDP-43 pathology via pyramidal tract induces ALS-like phenotypes in TDP-43 transgenic mice
by: Xuebing Ding, et al.
Published: (2021-01-01)

Chaperone Mediated Autophagy Degrades TDP-43 Protein and Is Affected by TDP-43 Aggregation
by: Fernando Ormeño, et al.
Published: (2020-02-01)

Aggregation of TDP-43 fragments triggers cellular aberrant function: implication in neurodegeneration
by: Che Meixia, et al.
Published: (2012-02-01)

TDP-43 domain structure and aggregation studies
by: 王宜婷
Published: (2011)

In vitro prion-like behaviour of TDP-43 in ALS
by: Phillip Smethurst, et al.
Published: (2016-12-01)

The aggregation and neurotoxicity of TDP-43 and its ALS-associated 25 kDa fragment are differentially affected by molecular chaperones in Drosophila.
by: Jenna M Gregory, et al.
Published: (2012-01-01)

TDP-43: From Alzheimer’s Disease to Limbic-Predominant Age-Related TDP-43 Encephalopathy
by: Wendi Huang, et al.
Published: (2020-02-01)

TDP-43 mislocalization drives neurofilament changes in a novel model of TDP-43 proteinopathy
by: Rachel Atkinson, et al.
Published: (2021-02-01)

NMR Fragment-Based Screening against Tandem RNA Recognition Motifs of TDP-43
by: Gilbert Nshogoza, et al.
Published: (2019-06-01)

TDP-43 regulates cancer-associated microRNAs
by: Xiaowei Chen, et al.
Published: (2017-09-01)

The pathological phenotypes of human TDP-43 transgenic mouse models are independent of downregulation of mouse Tdp-43.
by: Ya-Fei Xu, et al.
Published: (2013-01-01)

TDP-43 and Phosphorylated TDP-43 Levels in Paired Plasma and CSF Samples in Amyotrophic Lateral Sclerosis
by: Yuting Ren, et al.
Published: (2021-06-01)

A robust TDP-43 knock-in mouse model of ALS
by: Shih-Ling Huang, et al.
Published: (2020-01-01)

Insight into the Folding and Dimerization Mechanisms of the N-Terminal Domain from Human TDP-43
by: Mirella Vivoli-Vega, et al.
Published: (2020-08-01)

C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress
by: Masters Colin L, et al.
Published: (2011-08-01)

Diacritical Effects of ALS-Associated TDP-43 Mutations on ALS Pathogenesis in Homologous Knock-in Mice
by: Shih-Ling Huang, et al.
Published: (2019)

Mechanisms and models of TDP-43 proteinopathies
by: Petrucelli Leonard
Published: (2012-02-01)

Molecular Neuropathology of TDP-43 Proteinopathies
by: Manuela Neumann
Published: (2009-01-01)

Studies of VAPB and TDP-43 in neurodegeneration
by: Müller, Sarah
Published: (2015)

Divergent phenotypes in mutant TDP-43 transgenic mice highlight potential confounds in TDP-43 transgenic modeling.
by: Simon D'Alton, et al.
Published: (2014-01-01)

Oxidative stress induced by glutathione depletion reproduces pathological modifications of TDP-43 linked to TDP-43 proteinopathies
by: Yohei Iguchi, et al.
Published: (2012-03-01)

TDP-43 Oligomerization and Phase Separation Properties Are Necessary for Autoregulation
by: Ayala, Y.M, et al.
Published: (2022)

Cannot write session to /tmp/vufind_sessions/sess_16bjejct22eb5he24mc5ss9g1s